Coronavirus vaccine developer CureVac raises $213.3 million in U.S....

partage un lien

2020-08-14 12:42:04 -

Bill's latest investment https://finance.yahoo.com/news/coronavirus-vaccine-developer-curevac-raises-104458131.html

FINANCE.YAHOO.COM

Coronavirus vaccine developer CureVac raises $213.3 million in U.S. IPO

The German biotechnology firm, backed by Microsoft Corp founder and billionaire Bill Gates, sold 13.33 million shares at $16 apiece, the top end of its indicated price range of between $14 and $16 per share. CureVac is researching how to use messenger RNA to treat a series of diseases, including the

0 Commentaires 0 Parts 635 Vue

Commandité

We are 100% funded for October.

Thanks to everyone who helped out. 🥰

Xephula monthly operating expenses for 2024 - Server: $143/month - Backup Software: $6/month - Object Storage: $6/month - SMTP Service: $10/month - Stripe Processing Fees: ~$10/month - Total: $175/month

Please Donate Here